GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Giant Biogene Holding Co 2367.HK · HKD

Consumer Staples · HKEX · 🇭🇰 Hong Kong

Compare

20.38

-1.36%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥6.43bn

FY2019FY2025

Net income

CN¥2.23bn

FY2019FY2025

Free cash flow

CN¥1.72bn

FY2019FY2025

Shareholders' equity

CN¥11.55bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueCN¥6.43bnCN¥5.54bnCN¥3.52bnCN¥2.36bnCN¥1.55bnCN¥1.19bnCN¥1.11bn
Gross profitCN¥5.16bnCN¥4.55bnCN¥2.95bnCN¥2.00bnCN¥1.35bnCN¥1.01bnCN¥927.7m
Research and developmentCN¥103.4mCN¥106.5mCN¥75.0mCN¥44.0mCN¥25.0mCN¥13.4mCN¥13.3m
Operating incomeCN¥2.47bnCN¥2.31bnCN¥1.66bnCN¥1.13bnCN¥914.6mCN¥806.8mCN¥801.8m
Net incomeCN¥2.23bnCN¥2.06bnCN¥1.45bnCN¥1.00bnCN¥828.1mCN¥826.5mCN¥643.0m
Diluted earnings per share2.082.061.511.020.840.830.65

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsCN¥12.63bnCN¥9.36bnCN¥5.79bnCN¥3.65bnCN¥7.88bnCN¥2.65bnCN¥2.09bn
Cash and short-term investmentsCN¥9.66bnCN¥6.82bnCN¥4.40bnCN¥2.56bnCN¥7.26bnCN¥1.96bnCN¥953.6m
Total liabilitiesCN¥1.07bnCN¥1.07bnCN¥701.0mCN¥350.7mCN¥6.86bnCN¥2.19bnCN¥751.6m
DebtCN¥11.3mCN¥6.7mCN¥2.7mCN¥2.6m———
Shareholders' equityCN¥11.55bnCN¥8.28bnCN¥5.08bnCN¥3.30bnCN¥1.02bnCN¥458.0mCN¥1.34bn
Shares outstanding1,070m1,002m960m987m992m992m992m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operationsCN¥2.21bnCN¥2.04bnCN¥1.92bnCN¥1.08bnCN¥692.4mCN¥834.1mCN¥764.4m
Capital spending−CN¥485.6m−CN¥246.8m−CN¥266.0m−CN¥178.4m−CN¥111.2m−CN¥76.3m−CN¥133.8m
Free cash flowCN¥1.72bnCN¥1.79bnCN¥1.65bnCN¥906.3mCN¥581.2mCN¥757.8mCN¥630.6m
Dividends paid−CN¥1.45bn−CN¥908.4m—−CN¥427.9m−CN¥2.55bn——

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥3.35bnCN¥2.80bnCN¥3.62bnCN¥3.00bnCN¥2.54bnCN¥1.92bnCN¥1.61bnCN¥1.38bn
Gross profitCN¥2.66bnCN¥2.20bnCN¥2.96bnCN¥2.45bnCN¥2.09bnCN¥1.60bnCN¥1.35bnCN¥1.16bn
Operating incomeCN¥1.06bnCN¥885.7mCN¥1.58bnCN¥1.22bnCN¥1.09bnCN¥897.1mCN¥714.7mCN¥627.9m
Net incomeCN¥1.08bnCN¥853.2mCN¥1.38bnCN¥1.08bnCN¥983.2mCN¥784.8mCN¥666.9mCN¥385.0m
Diluted earnings per share1.020.801.291.080.980.820.690.39
Cash from operations—CN¥1.35bnCN¥833.0mCN¥1.12bnCN¥922.0mCN¥954.0mCN¥692.0mCN¥620.0m
Capital spending—−CN¥176.0m−CN¥324.0m−CN¥81.0m−CN¥165.0m−CN¥39.0m−CN¥186.0m−CN¥110.0m
Free cash flow—CN¥1.18bnCN¥509.0mCN¥1.04bnCN¥757.0mCN¥915.0mCN¥506.0mCN¥510.0m
Total assetsCN¥11.93bnCN¥12.63bnCN¥13.14bnCN¥8.04bnCN¥7.78bnCN¥4.97bnCN¥3.88bnCN¥3.65bn
Cash and short-term investmentsCN¥8.61bnCN¥9.66bnCN¥10.32bnCN¥5.86bnCN¥6.06bnCN¥3.78bnCN¥2.78bnCN¥2.56bn
DebtCN¥9.8mCN¥11.3mCN¥8.1mCN¥6.7mCN¥1.5mCN¥2.7mCN¥2.1mCN¥1.0m
Shareholders' equityCN¥10.89bnCN¥11.55bnCN¥10.69bnCN¥7.11bnCN¥5.97bnCN¥4.36bnCN¥3.51bnCN¥3.30bn

Financial ratios

Data as of 21 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin80.3%82.1%83.6%84.4%87.2%84.6%
Operating margin38.4%41.7%47.2%47.9%58.9%67.8%
Net margin34.7%37.2%41.2%42.4%53.3%69.4%
Return on equity19.3%29.0%33.3%35.4%81.4%180.4%
Return on assets17.7%25.7%29.2%31.9%10.5%31.2%
Free cash flow yield8.8%9.3%7.9%4.5%3.3%3.7%
Revenue growth-0.4%57.2%49.0%52.3%30.4%24.4%
Earnings growth-7.2%42.1%44.9%21.0%0.2%49.6%
Current ratio11.27x7.66x7.79x9.03x1.09x1.05x
Debt to equity0.00x0.00x0.00x0.00x0.00x0.00x
Equity ratio91.4%88.4%87.7%90.3%12.9%17.3%
Interest coverage7022.46x9659.55x14864.94x53959.05x20.11x4.90x
R&D as a share of sales1.6%1.9%2.1%1.9%1.6%1.1%
Buybacks as a share of market value-6.8%-4.4%2.8%0.5%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue39.5%40.1%—
Operating income29.6%25.1%—
Net income30.6%22.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin81.1%82.1%82.6%—
Operating margin39.9%42.4%45.1%—
Net margin35.9%37.8%40.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings13.821.120.428.7
Price to sales4.87.98.412.2

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 17 Jun 2025.

FY2025FY2024
Paid in the year0.6580.48

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.